BioAtla Investor Presentation Deck slide image

BioAtla Investor Presentation Deck

Phase 1 CAB-CTLA-4 (BA3071): Demographics - Baseline Patient Characteristics Median of at least 3 prior lines of treatment bicatla Data Cut Date: 15Nov23 Age, y, mean (range) ECOG Status, n (%) 0 1 # of prior systemic therapies, n (%) 1 23 ≥4 Total (N=18) 65.5 (43-79) 10 (55.6) 8 (44.4) 5 (27.8) 2 (11.1) 4 (22.2) 7 (38.9) BioAtla| Overview 13
View entire presentation